In this week's edition...
 
— CMS To Receive ICER Study as Part of Medicare Drug Price Negotiation Program. See details below.
— PCORI Accepting Nominations for Methodology Committee. Click here to learn more and submit a nomination.
— PCORI Engagement Awards: Letters of Intent Due Thursday! Click here to learn more.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— PCORI Engagement Awards: Letters of Intent Due Thursday. See details below.
— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— 38 Organizations Comment on Maryland PDAB UPL Plan. See details below.
— NCD Releases Report on People with Disabilities in Clinical Trials. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— PCORI Annual Meeting October 22-23, 2024. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— 38 Organizations Comment on Maryland PDAB UPL Plan. Click here to view the letter.
— Register for Cancer Support Community's Second Annual Inflation Reduction Act (IRA) Stakeholder Summit. See details below.
— Register for AFPA National Policy & Advocacy Summit. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— NCD Releases Report on People with Disabilities in Clinical Trials. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders.  Click here to view.
— PCORI Annual Meeting October 22-23, 2024. See details below.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...

— Advancing H.R. 485, the Protecting Health Care for All Patients Act. See details below.
— 38 Organizations Comment on Maryland PDAB UPL Plan. Click here to view the letter.
— Register for Cancer Support Community's Second Annual Inflation Reduction Act (IRA) Stakeholder Summit. See details below.
— Register for AFPA National Policy & Advocacy Summit. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— NCD Releases Report on People with Disabilities in Clinical Trials. See details below.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders.  Click here to view.
— PCORI Annual Meeting October 22-23, 2024. See details below.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.